Knapp R J, Vaughn L K, Fang S N, Bogert C L, Yamamura M S, Hruby V J, Yamamura H I
Department of Pharmacology, College of Medicine, University of Arizona, Tucson.
J Pharmacol Exp Ther. 1990 Dec;255(3):1278-86.
[N-methyl-Nle28,31]CCK26-33 (SNF 8702) is a nonsulfated cholecystokinin octapeptide analog that is highly selective for cholecystokinin-B (CCK-B) receptors. Inhibition studies using [125I] Bolton-Hunter-labeled CCK-8 show that SNF 8702 has over 4,000-fold greater affinity for CCK receptors in guinea pig cortex relative to those in guinea pig pancreas. SNF 8702 was tritium-labeled to a specific activity of 23.7 Ci/mmol and its binding properties characterized for guinea pig brain membrane preparations. [3H]SNF 8702 binds to a single site with high affinity (Kd = 0.69-0.90 nM) in guinea pig cortex, cerebellum, hippocampus and pons-medulla. Of these four tissues, the highest receptor density was measured in the cortex (86 fmol/mg of protein) and the lowest in the pons-medulla (22 fmol/mg of protein). In contrast to findings of single-site binding in some brain regions, evidence for CCK-B receptor heterogeneity is observed under other conditions. [3H]SNF 8702 binding to membranes prepared from whole guinea pig brain shows biphasic association kinetics at a concentration of 2.0 nM consistent with the presence of binding site heterogeneity. Binding site heterogeneity is consistently observed for [3H]SNF 8702 binding to guinea pig whole brain membranes in saturation studies where a high-affinity site (Kd = 0.31 nM) is distinguished from a low-affinity site (Kd = 3.3 nM). Binding site heterogeneity is also observed for the midbrain-thalamic region. CCK-B receptor heterogeneity is suggested by the effect of the guanyl nucleotide analogue, guanylyl-imidodiphosphate (Gpp(NH)p), on [3H]SNF 8702 binding to CCK-B receptors in the cerebellum.(ABSTRACT TRUNCATED AT 250 WORDS)
[N-甲基-Nle28,31]CCK26 - 33(SNF 8702)是一种非硫酸化的胆囊收缩素八肽类似物,对胆囊收缩素B(CCK - B)受体具有高度选择性。使用[125I]博尔顿 - 亨特标记的CCK - 8进行的抑制研究表明,相对于豚鼠胰腺中的CCK受体,SNF 8702对豚鼠皮质中的CCK受体的亲和力高4000倍以上。SNF 8702被氚标记至比活为23.7 Ci/mmol,并对其与豚鼠脑膜制剂的结合特性进行了表征。[3H]SNF 8702在豚鼠皮质、小脑、海马体和脑桥 - 延髓中以高亲和力(Kd = 0.69 - 0.90 nM)结合至单一位点。在这四种组织中,皮质中的受体密度最高(86 fmol/mg蛋白质),脑桥 - 延髓中的最低(22 fmol/mg蛋白质)。与某些脑区中单一结合位点的发现相反,在其他条件下观察到CCK - B受体异质性的证据。[3H]SNF 8702与从整个豚鼠脑制备的膜结合在2.0 nM浓度下显示出双相结合动力学,这与结合位点异质性的存在一致。在饱和研究中,[3H]SNF 8702与豚鼠全脑膜结合始终观察到结合位点异质性,其中高亲和力位点(Kd = 0.31 nM)与低亲和力位点(Kd = 3.3 nM)得以区分。中脑 - 丘脑区域也观察到结合位点异质性。鸟苷酸类似物鸟苷酰 - 亚氨二磷酸(Gpp(NH)p)对[3H]SNF 8702与小脑中CCK - B受体结合的影响表明存在CCK - B受体异质性。(摘要截短于250字)